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Abstract.  Many peptide hormones are synthesized as 
larger precursors which undergo endoproteolytic cleav- 
age at paired basic residues to generate a bioactive 
molecule.  Morphological evidence from several 
laboratories has implicated either the TGN or imma- 
ture secretory granules as the site of prohormone 
cleavage. To identify the site where prohormone cleav- 
age is initiated,  we have used retrovirally infected rat 
anterior pituitary GH3 cells which express high levels 
of prosomatostatin (proSRIF) (Stoller, T. J., and D. 
Shields. J.  Cell Biol.  1988.  107:2087-2095).  By in- 
cubating these cells at 20°C, a temperature that pre- 
vents exit from the Golgi apparatus,  proSRIF accumu- 
lated quantitatively in the TGN and no proteolytic 
processing was evident; processing resumed upon 
shifting the cells back to 37°C.  After the 20°C block, 
the cells were mechanically permeabilized and pro- 
SRIF processing determined.  Cleavage of proSRIF to 
the mature hormone was ~35-50%  efficient, required 
incubation at 37°C and ATP hydrolysis, but was inde- 
pendent of GTP or cytosol. The in vitro ATP- 
depeftdent proSRIF processing was inhibited by inclu- 
sion of chloroquine,  a weak base, CCCE  a protono- 
phore, or by preincubating the permeabilized cells 
with low concentrations of N-ethylmaleimide,  an in- 
hibitor of vacuolar-type ATP-dependent proton pumps. 
These data suggest that:  (a) proSRIF cleavage is initi- 
ated in the TGN,  and (b) this reaction requires an 
acidic pH which is facilitated by a Golgi-associated 
vacuolar-type ATPase.  A  characteristic  feature of poly- 
peptide hormone-producing cells is their ability to 
store the mature hormone in dense core secretory 
granules.  To investigate the mechanism of protein sort- 
ing to secretory granules,  the budding of nascent 
secretory vesicles from the TGN was determined.  No 
vesicle formation occured at 20°C;  in contrast,  at 
37°C, the budding of secretory vesicles was ~40% 
efficient and was dependent on ATP,  GTP, and cyto- 
solic factors. Vesicle formation was inhibited by 
GTP'yS suggesting a role for GTP-binding proteins in 
this process. Vesicle budding was dependent on cyto- 
solic factors that were tightly membrane associated 
and could be removed only by treating the permeabi- 
lized cells with high salt.  After high salt treatment, 
vesicle formation was dependent on added cytosol or 
the dialyzed salt extract.  The formation of nascent 
secretory vesicles contrasts with prosomatostatin pro- 
cessing which required only ATP for efficient cleav- 
age.  Our results demonstrate that prohormone cleavage 
which is initiated in the TGN, precedes vesicle forma- 
tion and that processing can be uncoupled from the 
generation of nascent secretory vesicles. 
p 
EPTIDE hormones of less than  "~50 amino acids are 
initially  synthesized  as  large  inactive  polyprotein 
precursors or prohormones. Many prohormones have 
complex structures comprising precursors encoding  multi- 
ple repeating units of identical or unrelated peptides flanked 
by pairs of basic amino acids or, less frequently, single basic 
Preliminary accounts of this work were presented at the Annual Meeting 
of the Endocrine  Society (1991) and American  Society for Cell Biology 
(1991). 
Please address all correspondence to Dr. Dennis Shields, Departments 
of Anatomy and Structural Biology and Developmental and Molecular Bi- 
ology, Albert Einstein College of Medicine,  1300 Morris  Park Avenue, 
Bronx,  NY  10461. 
residues (20, 29). Endoproteolytic cleavage at specific sets 
of basic residues results in excision of the peptide which may 
then undergo additional  biochemical modifications  such as 
acetylation, amidation,  sulfation, etc., to generate a biologi- 
cally active hormone.  Morphological and biochemical evi- 
dence suggests that these modifications occur sequentially in 
the distal secretory pathway, including  the TGN, immature 
and  mature  secretory granules  (20,  45,  49,  65).  Conse- 
quently,  the biosynthesis of peptide hormones represents a 
good model to understand protein processing and membrane 
trafficking.  In the past few years several prohormone cleav- 
age enzymes have been identified by using PCR techniques 
and oligonucleotides  corresponding to the active site of the 
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(for recent reviews see 51, 57). This approach has identified 
a family of proteases including  prohormone convertases or 
"PC's;  that  cleave  prohormones,  and a  related set of en- 
zymes,  designated  "furins", which  process  constitutively 
secreted and  membrane  glycoproteins  (22,  39,  58).  The 
coordinated expression of a subset of PC's,  along with that 
of a particular prohormone substrate,  may in part explain 
cell  and  tissue-specific  processing  of  peptide  hormone 
precursors (9, 63, 75).  Several recent reports have demon- 
strated  that  the PC's themselves undergo posttranslational 
processing (2, 26, 68). At present, relatively little is known 
about the intracellular  sorting and processing of the PC's or 
how they are copackaged with their respective prohormone 
substrates  to effect proteolytic processing. 
A characteristic  feature of polypeptide hormone-produc- 
ing cells is their ability to concentrate and store the mature 
hormone in dense core secretory granules.  Upon stimula- 
tion,  these granules fuse with the plasma membrane in a 
calcium-dependent  process, and release their contents  into 
the external  milieu.  This has been designated  "regulated" 
secretion  (13). In  contrast,  fibroblasts,  hepatocytes,  and 
plasma cells manifest "constitutive" secretion whereby secre- 
tory and plasma membrane proteins are transported in vesi- 
cles that continuously fuse with the plasma membrane in a 
calcium-independent  process  (13). Since  endocrine  ceils 
possess both constitutive  and regulated secretory pathways, 
a  mechanism  must exist  whereby the cell is able to sort 
different  classes of proteins to their appropriate secretory 
vesicles.  Morphological evidence from several laboratories 
has implicated  the TGN as the site of this protein sorting 
event (24, 31, 44, 49, 56, 65). Orci and colleagues (3, 42-45) 
using immunoelectron microscopy techniques demonstrated 
that proinsulin  cleavage is initiated in acidic, clathrin-coated 
immature  secretory  vesicles  that  bud  from  the  TGN, 
whereas mature insulin  is stored in secretory granules de- 
void of clathrin.  Subsequent morphological  data  from  a 
number of laboratories (31, 49, 56, 65) have provided evi- 
dence that prohormone endoproteolytic processing and sort- 
ing may occur in the TGN. Tooze et al.  (65) and Schnabel 
et al.  (49) demonstrated that  the TGN is the site of pro- 
opiomelanocortin (POMC) ~  processing and packaging  into 
nascent secretory granules.  Recent morphological studies on 
somatostatin biosynthesis have also suggested that its precur- 
sor is processed in the TGN (31). During and after sorting 
and packaging into regulated pathway vesicles, peptide hor- 
mone  precursors  undergo  posttranslational  processing  to 
generate bioactive molecules.  However,  the temporal and 
spatial relationship  between prohormone processing, selec- 
tive packaging  of mature hormones, and secretory granule 
formation  is poorly understood. 
To identify the intracellular  site of prohormone processing 
and packaging  of polypeptide hormones into nascent secre- 
tory vesicles, we have established a permeabilized cell sys- 
tem derived from rat anterior pituitary GH3 cells infected 
with a recombinant retrovirus  encoding preprosomatostatin 
(preproSRIF). Cell-free and permeabilized cells have been 
1. Abbreviations  used in this paper: BFA, brefeldin A; CCCP, carbonyl- 
cyanide m-ehlorophenylhydrozone; GH, growth hormone;  HA, hemagglu- 
tihin; HEM, N-ethylmaleimide; POMC, pro-opiomelanocortin;  SRIF, so- 
matostatin. 
used to successfully  reconstitute  intraGolgi  transport (47) 
and  ER to Golgi vesicular transport  (5) as well as other 
vesicular transport pathways (27, 48). By using  permeabi- 
lized cells or in vitro systems, several groups (23, 25, 38, 64) 
have recently investigated  polypeptide sorting  in the TGN 
and  the budding of secretory vesicles.  Tooze and Huttner 
(64) characterized  the formation  of two populations of im- 
mature secretory granules  in rat pheochromocytoma PC12 
cells in which secretogranin  II was packaged into regulated 
secretory pathway vesicles and heparin sulfate proteoglycan 
was  sorted to constitutive  vesicles; the formation  of both 
classes of vesicle required ATP and GTP.  More recently, 
Grimes and Kelly (25) observed the ATP-dependent  forma- 
tion of both constitutive  and regulated  immature  secretory 
vesicles in mechanically permeabilized PC12 cells. The con- 
stitutive vesicular transport of plasma membrane glycopro- 
teins from the TGN has also been investigated using permea- 
bilized cells and shown to be dependent on ATP hydrolysis 
(18). Likewise,  the sorting of influenza virus hemagglutinin 
(HA) to the apical  surface of permeabilized MDCK cells 
(23)  required  ATP  and  was  inhibited  by GTP3,S,  a  non- 
hydrolyzable analogue of GTP. Similarly, transport of vesic- 
ular stomatitis  virus G protein (VSV-G) from the Golgi ap- 
paratus to the plasma membrane could be reconstituted in 
CHO cells and was dependent on ATE GTP, and cytosolic 
factors  (38).  Although  earlier  studies  have  investigated 
proinsulin processing in isolated secretory granules (46), to 
our knowledge permeabilized cells have not been exploited 
previously to investigate a possible role for the Golgi appara- 
tus/TGN in prohormone processing. 
Somatostatin (SRIF) is a 14-amino acid peptide hormone 
that is synthesized as a part of a larger •120  residue precur- 
sor, preproSRIF (28).  Cleavage of the precursor at a single 
Arg-Lys pair, located near the carboxyl terminus of the mol- 
ecule, results in excision of the mature tetradecapeptide (41). 
Using  GH3  cells  which  secrete endogenous  growth  hor- 
mone  (GH),  we have  previously demonstrated  (59)  that 
proSRIF was accurately and efficiently processed and the 
mature hormone packaged into regulated secretory vesicles. 
Data from other investigators  have  shown  that  GH3 cells 
express only the PC2 member of the prohormone processing 
enzyme family (52). We have now used a 20°C temperature 
block to accumulate polypeptides in the TGN (18) and pre- 
pared permeabilized  GH3 cells.  This  system  was  able to 
support both prohormone  cleavage  and  the  formation  of 
nascent secretory vesicles.  Here we demonstrate that:  (a) 
proSRIF cleavage was initiated in the TGN; (b) cleavage re- 
quired ATP hydrolysis  to generate an intralumenal  acidic 
pH; and that (c) prohormone cleavage preceded the forma- 
tion of nascent secretory vesicles. In contrast to prohormone 
cleavage, secretory vesicle formation required both GTP and 
cytosolic factors as well as ATP. The cytosolic factors neces- 
sary for vesicle budding were tightly membrane associated 
and could be removed only by treatment with high salt. Our 
data demonstrate that prohormone cleavage in the TGN pre- 
cedes vesicle budding and that processing can be uncoupled 
from the formation  of immature  secretory granules. 
Materials and Methods 
Materials 
[35S]Cysteine was purchased at the highest available specific activity from 
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chased from Epicentre (Madison, WI). Carbonyl-cyanide m-chlorophen- 
yihydrozone (CCCP)  was purchased from CalBiochem (La Jolla,  CA). 
N-ethylmaieimide (NEM) was purchased from Pierce (Rockford, IL). Chlo- 
roquine was purchased from Sigma Chem. Co. (St. Louis, MO). GTP'yS 
and ATP~S were purchased from Boehringer Mannheim, Germany. Re- 
verse phase HPLC columns were purchased from Vydac (Hesperia, CA) or 
Dynamax Corporation, Rainin Instruments (Woburn, MA). Centricon S-10 
concentrators were obtained from Amicon  ® (Beverly,  MA). 
Antibodies. A monoclonai antibody to ribophorin I was a gift from Dr. 
Gert Kriebich, New York University Medical Center; rabbit anti TGN-38 
was from Dr. Paul Luzio, University of Cambridge, England. A rabbit an- 
tipeptide antiserum to the carboxy terminal 10 residues of rat growth hor- 
mone (RRFAESSCAF) was prepared exactly as described (19); initially this 
serum was generously provided by Dr. Richard Mains, Johns Hopkins Med- 
ical School. 
Methods 
Cell Culture. Cells were grown at 37°C in an atmosphere of 7.5%  CO2. 
GH3  cells were  grown  in  Ham's  F10  medium  (3  g/ml  NaHCO3)  sup- 
plemented with 15% equine serum, 2.5% FBS, 2 mM glutamine, 25 U/ml 
penicillin, and 25 mg/ml streptomycin. 
Pulse-Labeling and Immunoprecipitation. GH3. S18.9 cells were pulse- 
labeled with 500 ~Ci  [3SS]cysteine/ml  as previously described (59) and 
chased for various times as indicated at 20 or 37°C in the presence of 5 mM 
nonradioactive cysteine. At the end of the incubation, the cells and medium 
were treated with either anti-GH or anti-SRIF antibodies as previously de- 
scribed, except that SDS was omitted before antibody addition (59).  The 
samples  were  then  treated  with  protein  A-Sepharose  and  the  im- 
munoprecipitable material analyzed by SDS-PAGE or reverse phase HPLC 
(16) (see below). 
HPLC Analysis of SRIF-Immunoreactive Polypeptides. The antibody- 
antigen complexes bound to protein A-Scpharose were incubated in 500 
mM Tris-HC1,  pH 8.8, 20 mM EDTA, 8 M urea ("TEU") containing 100 
mM DTT at 65°C for 15 rain followed by carboxymethylation (59).  The 
protein A-Sepharose beads were centrifuged at 15,000 g for 5 min and the 
eluted peptides applied to  either of two different reverse phase HPLC 
columns: Gradient A  elution conditions: Vydac Cts (25 cm  ×  4.6 mm) 
column eluted by 0-5 rain 5% CH3CN;  5-6 min 5-20% CH3CN; 6-36 
rain 20-35%  CH3CN;  36-51  min 35-50%  CH3CN;  51-52 min 50-80% 
CH3CN. Gradient B: Dynamax C4 (5 cm ×  4.6 nun) column (Rainin In- 
struments) eluted with 0-4 min 5%  CH3CN; 4-6 rain 5-25%  CH3CN; 
6-21 min 25-32% CH3CN; 21-33 rain 32-46% CH3CN; 33-37 min 46% 
CH3CN; 37-38 rain 47-80% CH3CN. Each gradient was eluted at a flow 
rate of 1.5 mi/min and all solutions contained 0.1% trifluoroacetic acid. The 
columns were eluted using a Waters-Millipore HPLC system, fractions of 
1 rain were collected and the radioactivity determined by liquid scintillation 
counting. Prosomatostatin processing efficiency was determined by com- 
paring the radioactivity in only the peak fraction of mature SRIF divided 
by that present in the peak fraction of proSRIF plus mature SRIE 
Preparation of PermeabUized GHs.SI&9 Cells. Each experiment was 
repeated at least twice. Approximately 2  ×  106 cells were pulse-labeled 
with [35S]cysteine  (500  tzCi/ml) for  10 min at 37"C,  washed with PBS 
(prewarmed to 200C), and chased for 2 h at 20"C in medium containing 
5 mM Cys. To ensure maintenance of a neutral pH during the chase period, 
the incubation media were supplemented with 25 mM Hepes KOH, pH 7.2. 
At the termination of incubation, ceils were permeabilized exactly as de- 
scribed by Beckers et al. (8). Briefly, cells were incubated at 4°C in swelling 
buffer for 5  min, the buffer aspirated and replaced with  1 ml "breaking 
buffer" (90 mM KCI, 10 mM Hepes, pH 7.2) after which the cells were bro- 
ken by scraping with a  rubber policeman. The cells were centrifuged at 
800 g for 5 min, washed in 3-5 ml of breaking buffer, and resuspended in 
5 vol of breaking buffer. This procedure resulted in >95 % of cell breakage, 
evaluated by staining with Trypan blue. Incubations were in a final volume 
of 300/~1 and contained: 120/~1 permeabilized cells (equivalent to 5-8  × 
10  s  cells),  120  tzl  cytosolic  extract  ('~180-240  t~g  protein),  2.5  mM 
MgCl2, 0.5 mM CaCI2,  110 mM KC1, 1 mM ATE 0.02 mM GTP,  10 mM 
creatine phosphate, 80 izg/ml creatine phosphate kinase and protease inhibi- 
tors (16). Incubations were at 20 or 37°C as indicated, at the end of which 
aliquots were treated with cell lysis buffer (above) followed by incubation 
with anti-GH and/or anti-SRIF antibodies. 
Preparation of Cytosol. GH3.S18.9  cells were pelleted at 800 g  for 5 
min, and washed once in homogenization buffer containing 125 mM KC1, 
25 mM Hepes KOH, pH 7.4 (7). The cells were resuspended in homogeni- 
zation buffer (1 vol of cell pellet to 5 vol of buffer) followed by homogeniza- 
tion using a stainless steel bail bearing homogenizer. The homogenate was 
centrifuged for 1 h at 39,000 rpm in a Beckman SW 50.1 rotor and the super- 
natant applied to a Sephadex G-25 column equilibrated with homogeniza- 
tion buffer (Beckman Instr., Inc., Fullerton, CA).  Desaited cytosol was 
concentrated using Centricon-3 concentrator and frozen in aliquots in liquid 
nitrogen. 
Formation of Nascent Secretory Vesicles in Permeabilized Cells. The 
permeabilized cells were incubated for 90 or 120 min at either 37 or 20°C 
in the presence of I mM ATE 0.02 mM GTP and 1 mg cytosolic protein/ml. 
At the end of the incubation, aliquots were digested with 100 t~g proteinase 
K/ml at 4°C for 30 rain; when present Triton X-100 was used at a final con- 
centration of 1%. Protcolysis was terminated by addition of 2 mM PMSF. 
After proteinase K digestion, the permeabilized cells were centrifuged in 
a Brinkman microfuge (15,000 g) for 2 min at 4°C. The pellets were treated 
with cell lysis buffer (59) and the lysates from permeabilized cells and the 
in vitro formed vesicles were treated with buffer A (2% Triton X-100,  150 
mM NaCI, 0.2 mM EDTA,  1 mM PMSF, 50 mM Tris HC1, pH 8.3) fol- 
lowed by 5/~1 of rabbit anti-GH or anti-SRIF serum. 
High Salt Extraction of PermeabUized Cells. Approximately 2-5  x 
10  s GH3.S18.9  cells were pulse-labeled for 10 rain at 370C,  chased 2 h at 
200C, and permeabilized (8). The permeabilized cells were washed three 
times with 3 ml of a physiological salt solution (100 mM KCI and 20 mM 
Hepes-KOH, pH 7.4) and resuspended in a volume corresponding to three 
times the packed cell volume. The salt concentration was adjusted to 400 
mM KC1 and the permeabilized ceils incubated for 10 min at 4°C. After 
high salt treatment, the permeabilized cells were centrifuged for 5 rain at 
800 g and the pellet resuspended in a volume of incubation buffer equivalent 
to that of the starting material. The salt extractable material in the superna- 
tant was dialyzed extensively against several changes of 1x  incubation 
buffer (100 mM KCI, 2 mM MgCI2,  10 mM Hepes KOH, pH 7.2) at 4°C 
and concentrated in a Centricon-10 concentrator to a final concentration of 
0.5 mg protein/ml. 
Equilibrium Density Sucrose Gradients. To isolate an enriched Golgi 
membrane fraction from GH3  cells, cells were homogenized using four 
strokes of a stainless steel ball-bearing homogenizer in 0.25 M sucrose, 10 
mM Tris-HC1,  pH 7.4,  and 1 mM MgAc2 (1 vol of cell pellet per 5 vol of 
homogenizing medium). The homogenate was adjusted to 1.4 M  sucrose 
and loaded onto a step gradient comprising: 2 ml of a 2.0 M sucrose cushion 
overlaid with '~2 ml of adjusted homogenate (loading material), 7 ml of 
1.2 M sucrose, and 2.2 ml of 0.8 M sucrose; all solutions contained 10 mM 
Tris-HCl, pH 7.4,  and 1 mM MgAc2.  The gradients were centrifuged for 
4.5 h at 39,000 rpm in a Beckman SW41Ti rotor.  1-ml fractions were col- 
lected from the top of each gradient and assayed for total protein by the 
method of Bradford (12), gaiactosyl transferase activity (14), siaiyl transfer- 
ase activity (11), TGN-38 (33) and ribophorin I (73), the latter two by West- 
ern blot. Each fraction was also assayed for GH and SRIF by sequential im- 
munoprecipitation  using  appropriate  antibodies  followed  by  protein 
A-Sepharose ( as above). 
Galactosyl Traasferase  and Sialyl ~nsferase Assays. Gaiactosyl trans- 
ferase and siaiyl transferase activities were determined as described by 
Chancy et ai. (14) and Bergeron et ai.  (11), respectively. 
Densitometry. The band intensity in each fluorngraph was quantitated 
using a Molecular Dynamics Model 300A computing densitometer and the 
data analyzed using the "Image Quant" 3.2 program (Molecular Dynamics, 
Inc., Sunnyvale, CA). 
Results 
We have previously established  and  analyzed a  cell  line 
designated GH3.S18.9 which is derived from rat anterior pi- 
tuitary GH3 cells infected with a recombinant retrovirus en- 
coding angler fish preproSRIF-I (59).  These cells process 
proSRIF to the mature hormone with '~75 % efficiency and 
target '~55 % of  the mature peptide to the regulated secretory 
pathway, however the endogenous GH is poorly stored (59). 
Our initial experiments were aimed at establishing condi- 
tions whereby GH and proSRIF would accumulate intracel- 
lularly in the TGN. To this end, we incubated GH3.S18.9 
cells  at  20°C,  a  temperature which  has  previously been 
shown to inhibit transport of membrane glycoproteins from 
the TGN (36). Ceils were pulse-labeled for 10 min at 37°C 
with [3sS]Cys, followed by a 0-120-min chase at 20°C. The 
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Figure 1.  (A) Incubation  at 20°C inhibits  GH secretion. GH3.S18.9 
cells were pulse-labeled with 500 #Ci/ml [35S]cysteine for 10 min 
and chased for the indicated times at 20°C (lanes 1-6) or at 37°C 
(lanes 7and 8). Samples of the culture medium (lanes 2, 4, 6, and 
8) and cell lysate (lanes 1, 3, 5, and  7) were treated  sequentially 
first with anti-SRIF antisera followed by protein A-Sepharose, and 
then with rabbit anti-GH antibodies and protein A-Sepharose (59). 
The  GH-immunoprecipitable  material  was  analyzed  on  a  15% 
polyacrylamide gel and subjected to fluorography.  Arrows indicate 
the position of GH and residual proSRIE (B) Incubation at 20°C 
inhibits proSRIF processing and secretion. The SRIF-immunoreac- 
tive  material  was  eluted  from  the  protein  A-Sepharose  beads 
(Methods) and the peptides resolved on a C4 reverse-phase HPLC 
column using a gradient of CH3CN in 0.1% TFA/water (Gradient 
B,  Methods).  Intracellular  material:  A,  C,  E,  and  G:  e---e. 
Secreted  material:  B,  D,  F,,  and  H:  o--o.  A  and  B)  SRIF  im- 
munoreactive material after  10-min pulse with [35S]Cys at 37°C. 
(C and D) SRIF immunoreactive polypeptides after 120-min chase 
at 37°C.  (E and F) SRIF-immunoreactive polypeptides chased at 
20°C for 60 rain.  (G and H) As C and D  but chased at 20°C  for 
120 min. Mature SRIF and proSRIF eluted at fractions 11 and 27, 
indicated by single and double asterisks, respectively. 
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Figure  2.  Kinetics  of  GH 
secretion  and  proSRIF  pro- 
cessing after shift from 20 to 
37°C.  GH3.S18.9 cells  were 
pulse  labeled  with  [35S]Cys 
for  10  min  at  37°C, and 
chased for 2 h at 20°C after 
which they were shifted back 
to 370C and incubated for the 
indicated times. Secreted and 
intracellular  GH-immunore- 
active  material  was  deter- 
mined by SDS-PAGE  followed 
by  fluorography  and  densi- 
tometry.  Somatostatin  poly- 
peptides were analyzed from 
the same samples by sequen- 
tial immunoprecipitation with 
anti-SRIF antibodies and the 
peptides  resolved by reverse 
phase  HPLC.  Secretion  of 
mature  SRIF:  ~--e;  pro- 
SRIF  secretion:  z~---~; GH 
secretion: D---~.  Inset: intracellular mature SRIF: ¢  ~.. Percent of SRIF-immunoreactive secreted material was calculated as: 
secreted SRIF material 
total (intracellular  +  secreted SRIF) 
x  100%. 
Note differences in left and right ordinates. Data are the average of two separate experiments. 
intracellular and secreted material was then analyzed for GH 
and SRIF-immunoreactive material (Fig. 1). In marked con- 
trast to incubation at 37°C where 85-90% of pulse-labeled 
GH was secreted by 120 min of chase (Fig. 1 a, lanes 7and 
8; Ref. 59), at 20°C "~95 % of the GH accumulated intracel- 
lularly (lanes 3-6). Similarly, there was virtually no secre- 
tion of unprocessed proSRIF at this temperature (Fig.  1 b). 
In agreement with our previous observations (59), at 37°C 
proSRIF was cleaved with ~80%  efficiency by 120 min of 
chase (C and D) and ~60% of the mature hormone (fraction 
11,  12) was stored intracellularly, although there was some 
constitutive secretion of unprocessed precursor and mature 
SRIF (D). Most significantly, even after 120 min incubation 
at 20°C, there was minimal proSRIF cleavage to the mature 
hormone  ('~6%)  and  like  GH,  greater than  95%  of the 
precursor accumulated within the cells. 
It was  possible that after incubation at 20°C,  GH,  and 
proSRIF, might be irreversibly trapped within the Golgi ap- 
paratus and would not be packaged into secretory vesicles 
when the cells were returned to 370C. To investigate this pos- 
sibility, GH3 ceils were pulse-labeled with psS]Cys, chased 
for 60 min at 20°C,  and then shifted to 37°C  for various 
times and the secretion of GH and proSRIF determined (Fig. 
2). Within 10 min of incubation at 370C,  ,x,25% of GH was 
secreted and greater than 70 % was recovered in the medium 
by 30 min of chase.  Thus the kinetics of growth hormone 
secretion were virtually identical to those of control cells in- 
cubated at 37°C alone (Fig.  1; Ref. 59). Similarly, the frac- 
tion of  unprocessed proSRIF secreted constitutively was also 
rapidly released upon shift from 20 to 37°C (Fig. 2). In con- 
trast to GH secretion, there was a lag in proSRIF processing 
after the shift from 20 to 37°C and in the appearance of the 
fraction of mature SRIF that is constitutively released. Most 
importantly, these data show that in the GH3 cells the 20°C 
block is completely reversible for both secretion and prohor- 
mone processing. These kinetics demonstrating differential 
GH and mature SRIF secretion are consistent with our previ- 
ous observations that SRIF is preferentially targeted to the 
regulated secretory pathway (59).  We interpret the lag in 
SRIF appearance to result from the requirement of proSRIF 
to undergo a series of reactions before secretion, namely en- 
doproteolytic cleavage, aggregation, and packaging into na- 
scent secretory vesicles. 
The 20°C Block Results in Prohormone Accumulation 
in the TGN 
The foregoing experiments suggested that GH and proSRIF 
accumulated intracellularly at 20°C.  Based on data  from 
previous investigators  (31,  49,  65),  we hypothesized that 
these molecules would be in the TGN. To identify the site 
of accumulation, we first used cell fractionation techniques 
(Fig. 3). Cells were pulse-labeled for 10 min at 37°C, chased 
for 2 h at 20°C, homogenized, and the post-nuclear super- 
natant  fractionated  on  an  equilibrium  sucrose  gradient 
designed to separate the ER and Golgi apparatus  (8).  An 
aliquot of each gradient fraction was transferred to nitrocel- 
lulose membranes and probed with antibodies to the TGN 
marker antigen TGN-38 (Fig. 3, panel A) and the ER marker 
ribophorin I (B). Each gradient fraction was also analyzed 
by  sequential  immunoprecipitation  for  SRIF-  and  GH- 
immunoreactive material (D and E, respectively), and the 
Golgi marker  enzymes,  sialyl and galactosyl transferases 
(C). Most of the proSRIF- and GH-immunoprecipitable ma- 
terial was recovered at the top of the gradient (fractions 2, 
3, and 4) in the same fractions as sialyl and galactosyl trans- 
ferase activities (fractions 3 and 4) and TGN-38 (fraction 3). 
Some residual proSRIF and most of the total protein re- 
mained in the load zone of the gradient (fractions 10 and 11) 
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Figure 3. Intracellular  accumulated GH and proSRIF cofractionate 
with Golgi markers.  Cells were  pulse-labeled with [35S]cysteine 
for 10 min at 37°C, chased at 20°C for 120 min, and homogenized. 
A post-nuclear supernatant was layered over a 2 M sucrose cushion 
and overlaid with 1.2 M and 0.8 M sucrose and centrifuged for 4.5 h 
at 150,000 g in a Beckman SW41Ti rotor (Methods).  1-ml  gradient 
fractions were collected from the top and assayed for: (A) TGN-38 
detected by Western blotting; (B) Ribophorin I, detected by West- 
ern blot;  (C)  galactosyl  transferase  (t3-----D), sialyl transferase 
(t~--~) and total protein (o----o); (D) SRIF-immunoreactive  ma- 
terial; (E) immunoprecipitable  GH material. Immunoprecipitates 
in D and E were analyzed by SDS-PAGE followed by fluorography. 
The arrows (D and E) indicate the position of proSRIF and GH, 
respectively. The asterisk  (E) indicates residual proSRIF present 
in the GH immunoprecipitate. 
as did greater than 95 % of the ER marker ribophorin I (B). 
These results suggest that both proSRIF and GH accumulate 
in the TGN after incubation at 20°C. 
Additional evidence that GH and proSRIF accumulated in 
the TGN at 20°C, was provided by use of the fungal metabo- 
lite  brefeldin  A  (BFA).  This  drug  inhibits  secretion  by 
preventing vesicle exit from the ER and leads to dissolution 
and redistribution of the Golgi apparatus (30). However, at 
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Figure 4.  Kinetics ofproSRIF and GH transport to a BFA-resistant 
compartment (TGN) at 200C. (A) ProSRIF processing occurs in a 
BFA-resistant compartment: Cells were pulse-labeled for 10 min at 
37°C with [35S]cysteine  and chased at 20°C for 30, 60, 90, or 120 
min. At each time point, cells were incubated for an additional 60 
min at 37°C in the absence (o---o) or presence (H)  of 10/zg 
BFA/ml. The media and cell lysate was then treated with anti-SRIF 
antibodies and the immunoreactive material analyzed by HPLC. 
Percent processing  is expressed  as: 
total mature SRIF 
×  100%.  mature SRIF +  proSRIF 
(B) GH transport from the late Golgi/TGN is not affected by BFA. 
Aliquots of the intracellular  and secreted material from the 60- and 
120-min samples (A) were treated with anti-GH antibodies and the 
GH-immunoprecipitable polypeptides  analyzed by  SDS-PAGE. 
The fluorograph  was quantitated by densitometric scanning. GH 
secretion in the absence of BFA, o--o; GH secretion in the pres- 
ence of 10 ~g BFA/ml, o---O. 
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Figure 5. ProSRIF processing in permeabilized GH3.S18.9 cells. Cells were pulse-labeled for 10 min at 37°C, chased for 120 min at 20°C 
and permeabilized as described (Ref. 8 and Methods). The perrneabilized cells were incubated for 90 min with cytosol and an energy 
generating system ("EGS" ATP, GTP, CP, and creatine phosphate kinase; Methods) either at 37°C (A), 4°C (B) or at 37°C in the absence 
of"EGS" (C). At the end of the incubation, samples were treated with anti-SRIF antibodies and the immunoprecipitable material analyzed 
using a C18 HPLC column (gradient A; Methods). Asterisks indicate the elution position of mature SRIF; proSRIF eluted at fractions 
32 and 33. (D) Kinetics of proSRIF cleavage in permeabilized cells. Samples were incubated exactly as in A for up to 180 min at 37°C 
(¢  ~,) or at 20°C (o---o) and proSRIF processing quantitated after resolution of precursor and mature immunoreactive forms by HPLC. 
early times after treatment, BFA has relatively little effect on 
the integrity of the TGN (15). Since the TGN has been impli- 
cated as the site of  prohormone endoproteolytic cleavage, we 
used BFA to determine (a) whether prohormone processing 
was  sensitive to BFA and (b) the transit time at 20°C  for 
proSRIF to reach a BFA-insensitive compartment, presum- 
ably the TGN. Cells were pulse-labeled for 15 min at 37°C, 
chased for up  to  120 min  at 20°C,  and  subsequently in- 
cubated for 1 h at 37°C in the presence or absence of 10/zg 
BFA/ml (Fig. 4). At early chase times (up to 60 min), pro- 
SRIF processing was inhibited by BFA consistent with the 
precursor residing in an early BFA-sensitive Golgi compart- 
ment.  By  60-90  min  of incubation  at  20°C,  a  low  but 
significant level of mature SRIF was apparent ("~25%). At 
120 min of chase, proSRIF had traversed the site of the BFA 
block and the level of  processing was significant ('~50-55 %) 
approaching  that  of control  non-BFA-treated cells  prein- 
cubated at 20°C. After 60 min of chase at 20°C, GH secre- 
tion was  also  BFA  sensitive.  However, when cells prein- 
cubated for 120 min at 20°C were then incubated at 37°C 
in the presence of BFA, GH secretion was similar to control 
levels (Fig. 4 B). These data show that in GH3 cells, BFA 
has little or no effect on late stages of secretion, i.e., TGN 
to plasma membrane, but significantly inhibits prohormone 
processing before the precursor reaches the TGN compart- 
ment.  These results also suggest that proSRIF takes '~90 
min at 20°C to traverse the site of the BFA block and that 
processing occurs in a post-BFA sensitive compartment. 
A  GH3 Permeabilized Cell System Supports 
Prohormone Cleavage 
Having  established  that  it  was  possible  to  accumulate 
significant levels of proSRIF  in  the  TGN,  permeabilized 
GH3.9 cells were prepared by the method of Beckers et al., 
(8). To investigate proSRIF processing in vitro, cells were 
pulse-labeled with [35S]cysteine for 10 min at 37"C, chased 
at 20°C for 120 min, transferred to 4°C, and permeabilized 
cells prepared. The permeabilized cells were incubated for 
90 min at 37°C in the presence of cytosol, GTP, an ATP- 
generating  system  (complete  system),  and  analyzed  for 
SRIF-immunoreactive material by HPLC (Fig. 5). After in- 
cubation at 370C (A),  "~28% of proSRIF (fraction 32) was 
cleaved to the mature fourteen amino acid peptide (fraction 
14)  and eluted with precisely the  same  retention time as 
SRIF or SRIF synthesized in intact cells. In contrast, incuba- 
tion at 37°C in the absence of ATP and GTP (B) or with the 
complete system at 4°C (C) resulted in minimal background 
processing of '~5 %. Proteolytic processing was linear up to 
'~90  min  incubation  at  37°C  whereas  only  background 
cleavage was  observed at  20°C  (D).  Efficient processing 
(~25-35%) to mature SRIF-14 was evident in the absence 
of cytosol and addition of up to 2 mg cytosolic protein/ml 
had little effect on processing efficiency (data not shown). 
These data suggested that only ATP and/or GTP might be 
necessary to effect prohormone cleavage in the TGN. To as- 
sess their respective requirement, permeabilized cells were 
incubated in the absence of either ATP, GTP, or both (Fig. 
6). Omission of ATP from the incubation system drastically 
inhibited proSRIF processing. In contrast, incubation in the 
absence of 0.02 mM GTP had relatively little effect on pro- 
hormone processing, resulting in '~21%  processing in the 
absence of GTP compared to '~25 % in the complete system 
(Fig. 6). Similarly, incubation in the presence of GTP'yS, a 
non-hydrolyzable GTP analogue  which  inhibits  vesicular 
transport in vitro (67) or with GDP-CP, had no significant 
effect  on processing efficiency. This result suggested that nei- 
ther GTP hydrolysis nor GTP-binding proteins are required 
for prohormone processing. As expected, omission of both 
ATP and GTP from the incubation system resulted in no 
proSRIF processing. The data demonstrate that cleavage of 
proSRIF to the mature tetradecapeptide hormone requires 
only ATP. 
ATP Hydrolysis Is Required to Generate an Acidic pH 
in the TGN 
Numerous reports (3, 40, 43, 60) have demonstrated that an 
acid environment is required for prohormone processing, 
sorting to the regulated secretory pathway and that the TGN 
and immature secretory granules have an acidic pH (3). Fur- 
thermore, several reports have demonstrated the presence of 
a  vacuolar  type  H+-ATPase  in  the  Golgi  apparatus  and 
secretory granule membranes (1, 21, 72, 76). Therefore, we 
hypothesized that the ATP requirement for proSRIF process- 
ing was to provide ener~ to establish a proton gradient in 
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Figure  6.  Requirements  for 
proSRIF  processing  in  per- 
meabilized  cells.  Pulse- 
labeled cells, chased for  120 
min at 20°C, were permeabi- 
lized  and  then  incubated  at 
37°C  with  1 mg/ml cytosol, 
under the indicated conditions 
for 90 min followed by treat- 
ment with anti-SRIF antibod- 
ies. Immunoreactive proSRIF 
and  mature  SRIF  were  re- 
solved  by  reverse-phase 
HPLC  and  the  efficiency of 
processing quantitated. When 
present, GTPqcS and GDP-CP 
were at a  final concentration 
of 20/~M. The data are the av- 
erage from  two  separate ex- 
periments. 
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Figure 7.  ATP hydrolysis is required to generate a proton gradient 
in the TGN.  Permeabilizexl cells were preincubated with 15/~M 
CCCP, 25/~M cMoroquine (CHLOROQ.), 10/~M NEM for 15 min 
at 4°C; control permeabilized cells were preincubated with buffer 
alone. The samples were then incubated for 120 min at 37"C with 
2 m_M ATP and the various inhibitors. Samples: "-ATE" (incubation 
in the absence of ATP), and ATP~,S (incubation in the presence of 
2  mM  ATP-yS).  SRIF-immunnoreaetive polypeptides were  ana- 
lyzed by HPLC. 
mature SRIF 
Percent processing =  mature SR1F  +  proSRIF  x  100%. 
Data were averaged from two separate experiments. 
the TGN and that this acidic pH would facilitate processing 
by the PC2  enzyme.  To test this idea, permeabilized cells 
were incubated with ATP or the non-hydrolyzable analogue 
ATP),S (Fig. 7).  ProSRIF cleavage was dependent on ATP 
hydrolysis since in the presence of 2  mM ATP~S there was 
minimal processing above background levels. That ATP hy- 
drolysis was required to generate an acidic milieu in the TGN 
was demonstrated by incubating the system in the absence or 
presence of either CCCP (a protonophore which would col- 
lapse a proton gradient), chloroquine, a weak base that neu- 
tralizes acidic organelles or with N-ethylmaleimide, which 
inactivates vacuolar ATPases (1) (Fig. 7). Consistent with the 
Figure 8.  Budding of nascent secretory vesicles from the TGN of 
permeabilized GH3.$18.9  cells.  Cells  were  pulse-labeled with 
[35S]cysteine for 10 min at 37°C, chased at 20°C for 2 h, permea- 
bilized and incubated for an additional 2 h at 37°C (lanes 1-6) or 
at 20°C (lanes 7-10) in the presence of cytosol, ATP, and GTE At 
the end of the incubation, aliquots were either untreated (lanes 1, 
2,  7, and 8) or treated with 100/zg proteinase K/ml (lanes 3-6, 9 
and 10) at 4°C for 30 min in the absence (lanes 3, 4, 9, and 10) 
or presence (lanes 5 and 6) of 1% Triton X-100. Control and pro- 
teinase K-digested samples were  then  centrifuged for 2  min  at 
15,000 g at 4°C, and the pellet  and supernatant treated with anti-GH 
serum.  The arrowhead indicates the migration of rat GH. 
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vesicle  budding  from  the 
TGN.  (A)  Energy  require- 
merits:  Pulse-labeled  cells, 
chased for 2 h at 20°C, were 
permeabilized  and  then  in- 
cubated with cytosol at 37°C 
for 2  h  in  the  absence  and 
presence of ATP and GTP as 
indicated. At the end of  the in- 
cubation,  samples were cen- 
trifuged for 2 rain at 15,000  g, 
the  supernatants  and  pellets 
were treated with anti-GH se- 
rum.  (B) Vesicle budding is 
inhibited  by  GTP~,S: Pulse- 
labeled  permeabilized  cells, 
prepared  as in A (Methods), 
were incubated for 2 h at 37°C 
with cytosol,  ATP, and GTP 
(lanes  1  and  2)  or  at  20°C 
(lanes 6 and 7) or with cytosol, ATE GTE and 20 #M GTP,yS (lanes 3 and 4). The samples were then centrifuged, and the supernatant 
and pellets treated with anti-GH serum and the immunoreactive material analyzed by SDS-PAGE, followed  by fluorography.  The arrowheads 
(A and B) indicate the position of rat GH. 
above hypothesis, incubation with either CCCP or chloro- 
quine decreased proSRIF cleavage by ~65-80%,  respec- 
tively, and pretreatment with low concentrations of N-ethyl- 
maleimide  inhibited  processing  by  ~50%.  These  results 
suggest that at least part of the requirement for ATP hydroly- 
sis is to generate an acidic milieu in the lumen of the TGN. 
Formation of Nascent Secretory Vesicles 
To determine if this system could support vesicle budding 
from the TGN and formation of immature secretory gran- 
ules, cells were pulse labeled with [35S]cysteine, chased for 
2 h at 20°C, permeabilized, and incubated for 2 h at 37°C. 
At the end of  the incubation, aliquots were digested with pro- 
teinase K in the absence and presence of 1% Triton X-100 
followed by brief centrifugation in a microfuge at 15,000 g. 
Control samples were incubated in the absence of proteinase 
K  followed by brief centrifugation. 
Aliquots of each pellet and supernatnant were then treated 
with either anti-GH (Fig.  8) or anti-SRIF antibodies (Fig. 
10). Our rationale was that small nascent secretory vesicles 
would  not  sediment  after short periods  of centrifugation 
(Methods) and the polypeptides contained within the lumen 
would be protease resistant if the membrane vesicles formed 
in vitro were sealed.  Approximately 40-60%  of the GH- 
immunoreactive material was found in the supernatant (lanes 
1 and 2) and ~70%  of this latter material was resistant to 
proteinase K  digestion (lanes 3  and 4).  All the protease- 
resistant GH was present in membrane bound vesicles since 
it  was  digested  quantitatively  when  proteolysis was  per- 
formed in the presence of Triton X-100 (lanes 5 and 6). Con- 
sistent with our data from whole cells, there was no vesicle 
budding  when  the  permeabilized cells  were  incubated  at 
20°C (lanes 7 and 8). These data demonstrated that GH is 
packaged into nascent secretory vesicles in vitro and that 
vesicle release is temperature-dependent. 
In contrast to prohormone cleavage which required only 
ATE vesicle budding from the TGN was dependent on both 
ATP and GTP (Fig. 9 A; lanes 1 and 2). Omission of ATP 
(lanes 3 and 4), GTP (lanes 5 and 6), or both (lanes 7 and 
8) from the incubation resulted in only minimal (•8-12%) 
or no vesicle formation. Based on observations using PC-12 
cells, we expected that budding of nascent secretory vesicles 
from the TGN would be inhibited by non-hydrolyzable ana- 
logues of GTP such as GTP'yS (6, 25,  64).  The permeabi- 
lized GH3 cells were incubated with GTP-yS in the presence 
of GTP and the formation of immature vesicles monitored 
(Fig. 9 B). Vesicle budding was inhibited significantly by ad- 
dition of GTP~,S (compare lanes 2  and 4) suggesting that 
GTP-binding proteins are involved in this process. Quantita- 
tion of the data in Figs.  8 and 9, by densitometry (Fig.  10 
A), demonstrated an absolute requirement for both ATP and 
GTP in the formation of nascent secretory vesicles. To deter- 
mine if mature SRIF and the uncleaved prohormone were 
also packaged into immature secretory vesicles, the pellets 
and supernatant fractions from the above incubations were 
also  analyzed  for  SRIF-immunoreactive  material  using 
HPLC methods and the data quantitated (Fig. 10, B and C). 
As with GH-containing vesicles, the formation of proSRIF 
or mature SRIF-containing vesicles required ATP and GTP. 
Vesicle release was inhibited by at least 50 % when the reac- 
tion contained 20 #M GTP~yS (Fig. 10 B); however, neither 
GTP~S  nor  GDP-CP  (non-hydrolyzable GTP analogues) 
affected proSRIF processing  (Fig.  6).  As  expected SRIF- 
vesicle formation was  inhibited  upon  incubation  at  20°C 
(Fig.  10 C). 
When intact cells were preincubated at 20°C and shifted 
back to 37°C,  *15% of GH was secreted by 15 min (Fig. 
2). In contrast, the kinetics of vesicle budding in permeabi- 
lized cells demonstrated that there was a lag of 15-20 min 
before the appearance of GH-containing vesicles upon incu- 
bation at 37°C (Fig.  11). This suggests that the membranes 
have to be "primed" perhaps by recruitment of cytoplasmic 
factors (see below) before vesicles can bud from the TGN. 
After the lag, vesicle budding was linear for up to 120 min 
at which time there was an abrupt plateau suggesting that the 
putative factor or factors may have become rate-limiting. 
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Figure 10. Budding efficiency 
of nascent secretory vesicles 
containing  GH-  and  SRIF- 
polypeptides.  Pulse-labeled 
cells were incubated at 200C 
for 2 h after which they were 
permeabilized and further in- 
cubated at 37 or 20"C for an 
additional  120 rain under the 
indicated conditions.  Samples 
were then separated  into pel- 
let and supernatant  fractions 
by centrifugation  at  15,000 g 
for 2 min,  treated  with anti- 
GH or anti-SRIF serum. The 
immunoprecipitates  were re- 
solved  by  SDS-PAGE  (GH) 
or  HPLC  (mature  and  pro- 
SRIF).  (A)  The  intensity  of 
each  GH band  in  the  pellet 
and supernatant  fractions,  in 
fluorographs  identical  to 
those shown in Figs.  8 and 9, 
was determined by densitom- 
etry.  Percent  budding  is  de- 
fined as: 
GH intensity  in 
supernatant 
x  100%.  GH intensity  in 
pellet+supernatant 
(B) Budding of vesicles  con- 
taining mature SRIE 
% budding  = 
mature SRIF in 
supernatant 
x  100%.  mature SRIF in 
pellet +supematant 
The asterisks indicate that ma- 
ture  SRIF  was  undetectable 
since proSRIF cleavage does 
not occur under these condi- 
tions.  (C)  Budding  of pro- 
SRIF containing vesicles. 
% budding  = 
proSRIF in 
supernatant 
x  100%.  proSRIF in 
pellet+supernatant 
In each case the data are the 
average  of two  separate  ex- 
periments. 
Role of Cytosolic Components in Vesicle Budding 
The preceding budding assays were performed in reactions 
supplemented with cytosol (a post-ribosomal supernatant). 
Based on other studies in which intracellular vesicular trans- 
port (8, 35, 47, 69) had an absolute requirement for cytosol, 
we hypothesized that cytosolic components would be neces- 
sary to facilitate budding from the TGN. Surprisingly, when 
the permeabilized cell system was washed sequentially three 
times with buffer containing 100 mM KC1 and the washed 
preparation incubated in the absence of cytosol, vesicle for- 
marion  still  occurred (Fig.  12;  lanes  7-12). Indeed under 
these conditions there was an '~50% increase in vesicle bud- 
ding efficiency compared to control levels (Table I). Further- 
more, there was no stimulation of vesicle formation above 
control levels when the washed permeab~  cells were in- 
cubated in the presence of cytosol. This rather unexpected 
result suggested that if cytosolic factors were necessary for 
vesicle formation, they would be bound tightly to the TGN 
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Figure 11. Kinetics of nascent vesicle formation. Pulse-labeled per- 
meabilized ceils were incubated in the presence  of cytosol, ATE 
and  GTP at 37°C  (=  =) or at 200C (o-----o). At the indicated 
times, aliquots were removed and separated into supernatant (vesi- 
cle) and pellet fractions by centrifugation  at 15,000 g for 2 min. 
Each fraction was treated with anti-GH serum and the immunopre- 
cipitable  material  resolved by SDS-PAGE followed by fluorogra- 
phy. The fluorogram was then analyzed by densitometry. 
membranes.  To  test  this  hypothesis,  permeabilized  cells 
were treated with high salt buffer (400 mM KC1) (Fig.  12, 
lanes 1-6) and the high salt-treated permeabilized cells as- 
sayed for vesicle budding in the absence or presence of con- 
trol cytosol or the dialyzed salt extract. Consistent with our 
hypothesis, the high salt-treated preparation was unable to 
support  vesicle budding  in  the  absence  of added  cytosol 
(lanes 3 and 4).  Furthermore, vesicle budding could be re- 
stored by addition of cytosol (compare lanes 1 and 2 and 3 
and 4). Most significantly, when the dialyzed salt extract was 
added to the salt-washed preparation,  vesicle budding  was 
restored to control levels (lanes 5 and 6 and Table I). As ex- 
pected, high salt treatment did not inhibit proSRIF process- 
ing to the mature peptide (Table I) and there was no stimula- 
tion of prohormone processing by incubation in the presence 
of the salt extract. These data are in agreement with our hy- 
pothesis that cytosolic components required for vesicle bud- 
ding are tightly bound to the surface of the TGN membrane. 
Discussion 
Recent evidence using EM immunogold techniques suggests 
that prohormone processing occurs in or is initiated in the 
TGN (31,  49,  65),  although  earlier morphological studies 
(43,  45) had implicated immature secretory granules as the 
site of proinsulin processing. Despite the recent identifica- 
tion of several key proteases involved in prohormone pro- 
cessing (51, 57), relatively little is known about the interac- 
tion of these enzymes with their prohormone substrates. For 
example, it is unclear how prohormones and the processing 
enzymes are sorted in the TGN and the mechanism of selec- 
tive packaging of mature hormone into  nascent secretory 
granules is poorly understood.  To understand the temporal 
and spatial relationship between prohormone processing and 
formation of nascent secretory vesicles, we have employed 
a permeabilized cell system similar to that used by other in- 
vestigators  to  investigate  ER  to  Golgi transport,  and  ex- 
ocytotic pathways (8, 35). By using a permeabilized cell sys- 
tem,  our  goal  is  to  identify  the  intracellular  site  of and 
factors necessary for prohormone processing. Furthermore, 
such  an  approach  should  also  facilitate  identification  of 
vesicular intermediates  that  mediate  selective sorting  and 
packaging  of peptide  hormones  into  immature  secretory 
granules.  During  protein  sorting  into  nascent  secretory 
granules, peptide hormone precursors undergo one or sev- 
eral posttranslational  modifications to  generate  a  biologi- 
cally active molecule  from the  relatively  inert precursor. 
Consequently,  the identification of the site and mechanism 
Figure  12.  Cytosolic  factors 
are requited for nascent secre- 
tory vesicle formation. Pulse- 
labeled cells were incubated at 
20°C for 2 h, permeabilized, 
and washed three  times  with 
physiological  salt  (100 mM 
KC1, lanes 7-12) or once with 
high salt (400 mM KCI, lanes 
1-6).  The  100  mM  KCI 
treated  pcrmeabilized  cells 
were incubated for 2 h at 37 or 
20°C (lanes 11 and 12) in the 
presence 0anes  7,  8,  11, and 
12) and absence (lanes 9 and 
10)  of  1  nag  cytosolic  pro- 
tein/ml. High salt-treated per- 
naeabilized  cells  were  in- 
cubated at 37°C with 1 mg/ml 
control  cytosol  (lanes  1  and 
2), no cytosol (lanes 3 and 4) or with 0.25 nag protein/ml  of dialyzed high salt extract (lanes 5 and 6). All samples contained ATP and 
GTE After incubation,  samples were separated into pellet and supernatant  fractions which were treated with anti-GH serum. The im- 
rnunoprecipitable  GH material  was resolved by SDS-PAGE followed by fluorography. The arrow indicates the position of rat GH. 
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Treatment  % proSRIF~  t  % Vesielell 
Processing  Budding 
% Control  % Control 
Control*  34.8  100  24.2  100 
Control,  no cytosol  32.7  94  37.0  152 
High salt  +  control cytosol§  27.8  80  27.6  114 
High salt wash, no cytosol  31.1  89  9.4  39 
High salt wash  +  high salt extract  29.6  85  30.0  124 
20°C  4.6  13  3.1  13 
* Control system: Permeabilized cells, washed three times with physiological salt and incubated with 1 mg cytosolic protein/ml,  1 mM ATP, 0.02 mM GTP, 
for 120 miu at 37°C. 
Determined from a single experiment. 
High salt wash: '~2-5  x  l0  s permeabilized cells were treated with 400 mM KCI, resuspended in reaction buffer (see Methods), and incubated as for control 
samples. The 400 mM KCI extracted material was dialyzed extensively against incubation buffer (100 mM KC1, 2 mM MgAe2, 0.5 mM CaCI2,  10 mM Hepes, 
~  H 7.4) before adding to the salt-treated permeabilized cells. 
Average of two experiments. 
of prohormone processing and formation of nascent secre- 
tory granules represents a critical step in understanding hor- 
mone action. 
The 20°C Block Prevents Prohormone Processing 
To address the first question, namely the site of prohormone 
cleavage,  we exploited an experimental protocol that has 
been used to trap viral envelope glycoproteins in the TGN, 
i.e., a 20°C block (18). By incubating cells at 20°C, we were 
able to accumulate quantitatively both GH and proSRIF in- 
tracellularly. Under these conditions there was no prohor- 
mone processing or secretion. Several lines of evidence are 
consistent with the transport and processing block occurring 
in the TGN. First, proSRIF and GH cofractionated on equi- 
librium sucrose gradients with the distal Golgi/TGN marker 
enzymes galactosyl and sialyl transferases as well as the 
marker protein TGN-38.  Second, processing occurred in a 
"late compartment" that was resistant to the drug BFA. At 
early chase times proSRIF cleavage was inhibited by BFA 
whereas at 90 min, processing was BFA-resistant. Third, the 
20°C block itself has been demonstrated to be selective for 
inhibiting vesicular transport from the TGN (18, 36). Finally, 
the most compelling evidence that prohormone cleavage is 
initiated in  the  TGN  comes  from experiments  in  which 
efficient processing occurred in the presence of ATP alone 
(Fig. 6) or after high salt treatment of the permeabilzed cells 
(Table I). Under either of  these conditions, there was no vesi- 
cle  budding  from  the  TGN,  yet  proSRIF  cleavage  was 
"o40-50 % efficient. Taken together, our results are consis- 
tent with the hypothesis that cleavage is initiated in the TGN 
and are in agreement with recent EM immunogold studies 
(31) demonstrating that proSRIF cleavage occurred in this 
organelle in rat hypothalamic neurons. However, our data do 
not exclude the possibility that processing continues in im- 
mature and mature secretory granules (17, 43, 46). 
The 20°C temperature block was particularly stringent in 
GH3 cells and only minimal levels of processing and secre- 
tion (,o6%) were seen even after 120 min incubation at this 
temperature. Our data therefore demonstrate that the 20°C 
block precedes the prohormone processing step in the secre- 
tory pathway. These results contrast with earlier reports that 
employed mouse pituitary AtT-20 cells (70) or primary cul- 
tures of rat cortical or hypothalamic cells (31). In AtT-20 
cells, POMC processing was reduced at 20°C because it was 
retained in the ER; however,  if POMC progressed to the 
Golgi apparatus, although its cleavage kinetics were slowed, 
processing was not inhibited (70).  Surprisingly, incubation 
of rat brain cortical fragments at 19°C resulted in the in- 
tracellular  accumulation of mature  SRIF-immunoreactive 
polypeptides. In particular the content of SRIF-28,  an NH2- 
terminally extended form of the tetradecapeptide, was in- 
creased significantly at reduced temperatures (31). The rea- 
son for the differences in temperature sensitivity between 
various cell lines is unclear at present but might reflect differ- 
ences in the respective lipid composition of  their Golgi mem- 
branes. Most importantly, the use of the 200C block to ac- 
cumulate proSR/F  in  the  TGN  enabled  us  to  develop  a 
permeabilized  cell  system  for  investigating  prohormone 
cleavage and formation of nascent secretory vesicles. 
ProSRIF Cleavage in Permeabilized Cells 
GH3 cells express the PC2 prohormone processing enzyme 
exclusively  (52)  and  proSRIF  cleavage  occurred  with 
"o35-50% efficiency in the permeabilized cells (Figs. 5 and 
7).  In contrast to vesicular transport which requires cyto- 
solic factors, ATE GTP, and GTP-binding proteins (5, 47), 
proSRIF processing needed only ATP hydrolysis (Fig. 7). 
We propose that the requirement for ATP hydrolysis is, in 
part,  to  provide  energy  for  a  vacuolar  type  H+-ATPase 
present in the Golgi membrane (72).  Since it is likely that 
the PC2 processing enzyme and proSRIF are in close prox- 
imity within the TGN, we postulate that efficient cleavage re- 
quires only conditions that are necessary for maximal en- 
zyme  activity.  Presumably  this  can  be  achieved  by  the 
H+-ATPase  which pumps  protons  into  the  lumen of the 
TGN thereby generating an acidic pH to activate the PC2 en- 
zyme. Our data are consistent with this hypothesis, since in- 
clusion of either the weak base chioroquine, the protono- 
phore CCCP, or N-ethylmaleimide (an inhibitor of vacuolar 
ATPases) in the incubation resulted in substantial (60-80 %) 
inhibition of proSRIF  processing.  We  speculate that the 
acidic pH may also induce conformational changes within 
proSRIF that expose paired basic residues to the processing 
enzyme. In addition, the acidic pH may function in facilitat- 
ing vesicular transport per se. In support of this hypothesis, 
Zeuzem et al. (76) showed that ADP-ribosylation factor, a 
small GTP-binding protein that functions in Golgi vesicle 
transport (30), required a low pH in the trans-Golgi to pro- 
mote its membrane binding. 
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oratory and others (3, 40, 60) using whole cells which dem- 
onstrate that an acidic milieu is required for prohormone 
processing and packaging to the regulated secretory path- 
way. In contrast, Mains and May (34)  have provided evi- 
dence that POMC processing and storage of mature peptides 
did not require a low pH compartment. However, our obser- 
vation that an acidic pH in the TGN is required for process- 
ing is also in agreement with earlier reports that proinsulin 
processing in isolated islet/3-cell secretory granules required 
ATP to activate an H+-ATPase which generated an acidic 
pH necessary for enzyme activity (46).  Davidson et al. (17) 
showed that/3-cell granules possess two proinsulin process- 
ing enzymes, designated type I and II, which were subse- 
quently shown to correspond to PC1/PC3 and PC2, respec- 
tively (4,  10). It is noteworthy that the islet type II activity 
(PC2) was optimal at ~pH 6.0--6.2 and at a Ca  2+ concentra- 
tion compatible with conditions prevailing in the late Golgi 
apparatus (17). Our demonstration that permeabilized GH3 
cells, which express only the PC2 enzyme, require an acidic 
pH in the TGN for proSRIF processing are quite consistent 
with these earlier reports and more recent data showing that 
purified PC1/PC3 and PC2 exhibit acidic pH optima (4, 55, 
74). Surprisingly, there was little or no proSRIF processing 
at 20°C either in intact GH3.S18.9 cells or in the permeabi- 
lized cell system, even after prolonged incubation. This sug- 
gests that the 20°C block may arrest proSRIF and/or PC2 in 
the TGN before the site of processing and that further trans- 
port or packaging, which requires  incubation at 37°C,  is 
necessary to bring the enzyme and substrate together to 
effect cleavage.  Given the slight lag in proSRIF processing 
after the shift from 20 to 37°C (Fig. 2), this explanation seems 
reasonable.  Alternatively, the  PC2  enzyme itself may be 
temperature sensitive; further experiments are in progress to 
address these points. 
Formation of Nascent Secretory Vesicles 
In polypeptide hormone secreting cells two classes of secre- 
tory vesicles have been characterized on the basis of  their ki- 
netics  of exocytosis,  namely constitutive- and  regulated- 
pathway vesicles. Mature regulated secretory vesicles can be 
readily identified morphologically by their dense core semi- 
crystalline protein content.  These vesicles are  stored  in- 
tracellularly and only released upon stimulation. In contrast, 
constitutive vesicles are less dense than regulated vesicles, 
are not stored, and continuously deliver their contents to the 
plasma membrane (13). Although these two pathways have 
been studied in some detail for the past several years, little 
is known about the molecular mechanism by which the cell 
discriminates between proteins destined for different vesicle 
populations. Morphological evidence has demonstrated that 
differential sorting and packaging of proteins occurs in the 
TGN (24, 44, 56) and the expression of chimeric proteins 
in heterologous cells suggests that the propeptide of some 
precursors may play a role in targeting to the regulated path- 
way (50,  54, 61). 
We also used the permeabilized GH3 cells to investigate 
the relationship between prohormone processing and forma- 
tion of secretory granules. Unlike PC12 cells where secre- 
tory vesicle formation could be achieved using a cell homog- 
enate (64),  we were unable to obtain vesicle budding if a 
post-nuclear supernatant was used rather than permeabilized 
cells. Similar observations have been made for ER to Golgi 
transport  (5);  thus  in  GH3  cells  it may be  necessary to 
maintain the structural integrity of the Golgi apparatus to 
facilitate vesicle budding (5,  35).  Vesicle  budding and re- 
lease of nascent secretory granules required GTP and cyto- 
solic factors in addition to ATP (Figs.  10 and 12).  These 
results show that prohormone processing in the TGN pre- 
cedes vesicle budding and that these two processes are sepa- 
rate biochemical reactions. Consequently, it should now be 
possible to separate immature secretory granules from con- 
stitutive vesicles as well as isolate vesicular intermediates in 
the formation of nascent secretory vesicles. Such studies are 
currently in progress. 
Several lines of evidence suggest that vesicle budding did 
not result from leakage of content from the TGN or from 
non-specific fragmentation of the Golgi apparatus:  (a) the 
released GH, proSRIE and mature SRIF were resistant to 
protease digestion (Fig. 8) and were only protease sensitive 
in the presence of Triton X-100, confirming that these poly- 
peptides are enclosed in membrane-bounded vesicles; (b) we 
observed no budding at 20°C even in the presence of ATP, 
GTP, and cytosol showing that budding requires physiologi- 
cal temperatures; (c) there was little or no budding in the ab- 
sence of ATP or GTP; and (d) high salt wash of the permea- 
bilized  cells  inhibited  vesicle  formation  significantly at 
37°C, demonstrating cytosolic factors are necessary to pro- 
mote vesicle budding. Finally, the nascent secretory vesicles 
contained <20 % of total siaiyl transferase activity (data not 
shown) suggesting that most of the Golgi vesicles remained 
associated with the permeabilized cells. 
Inhibition of Vesicle Formation by GTPTS 
In recent years, several laboratories have used in vitro sys- 
tems to investigate both regulated and constitutive secretory 
vesicle budding from the TGN (23, 25, 38, 64) and more re- 
cently fusion with the plasma membrane (27, 69).  Using 
PC12  cell homogenates,  elegant studies  from Tooze and 
Huttner (64) demonstrated the formation of both classes of 
vesicle which could be separated by appropriate sucrose gra- 
dients. Vesicle budding required ATP and was inhibited by 
GTP3,S implying that GTP-binding proteins are required for 
this process (66).  The immature secretory vesicles derived 
from the TGN were also demonstrated to be intermediates 
in the formation of mature secretory granules (67).  Grimes 
and Kelly (25)  have also obtained evidence for release of 
constitutive and immature regulated secretory granules de- 
rived from the TGN in vitro; in this case vesicle formation 
also required both ATP and GTP. Recently, heterotrimeric 
G-proteins have been implicated in regulating the formation 
of both constitutive and regulated pathway secretory vesicles 
(6, 25, 32, 62). In agreement with the observations of Tooze 
et al. (66), inclusion of GTP3,S in the incubation, inhibited 
GH- and SRIF-containing vesicle formation by '~50%, sug- 
gesting the involvement of  either small GTP-binding proteins 
or trimeric G-proteins in this process. Our GTP3,S  results 
and those of Tooze et al. (66) suggest that there may be a fun- 
damental difference between the formation of  POst-TGN vesi- 
cles and those which mediate intraGolgi transport. In the lat- 
ter case, Melan~on et al. (37)  showed that GTP'yS did not 
inhibit vesicle budding from Golgi membranes in vitro, but 
rather lead to accumulation of coated vesicles which were 
unable to fuse with acceptor Golgi membranes.  Further- 
more, the difference in these two vesicular processes is not 
related to formation of regulated pathway vesicles per se, 
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that post TGN constitutive vesicle formation is also inhibited 
by  GTP~/S.  We are  currently analyzing high  salt-treated 
Golgi membranes  (see  below)  to  identify putative GTP- 
binding proteins which may be specific for budding from the 
TGN. 
Role of Cytosol 
Rothman and colleagues have identified a number of cyto- 
solic factors which have been characterized in detail and are 
required for vesicle budding and fusion during intraGolgi 
transport (47). In addition, in all permeabilized cell systems 
described to date, cytosolic extracts or factors have been 
found necessary to support vesicle budding (53), exocytosis 
(48, 69), and endocytosis (47). Consequently, it was surpris- 
ing that upon washing the permeabilized cells sequentially 
with physiological strength buffers, the system maintained its 
capacity for vesicle budding in the absence of added cytosol 
(Fig. 12). Indeed, in several experiments, vesicle formation 
in the absence of cytosol was •50%  higher than in the com- 
plete system (Table I). One interpretation of this data is that 
inhibitory factors may be loosely associated with the TGN 
membrane and prevent vesicle release. Such putative factors 
would be expected to cycle between the cytoplasm and Golgi 
membrane and function to prevent vesicle budding in the ab- 
sence of "cargo molecules; i.e., mature hormones. In this 
context, it is noteworthy that Barr et al. (6) showed heterotri- 
merit G proteins can inhibit secretory vesicle formation in 
vitro in PC-12 cells. More recently, Leyte et al. (32) demon- 
strated that the God subunit of trimeric G proteins can nega- 
tively regulate budding of immature secretory granules from 
the TGN of PC12 cells. In agreement with the hypothesis that 
vesicle formation could be regulated by GTP-binding pro- 
teins, we also observed that vesicle budding was inhibited by 
GTP3,S.  Furthermore, in the presence of GTP alone, bud- 
ding was actually lower than when only ATP was present in 
the reaction (Figs.  3 and 5 B). This inhibition is consistent 
with the existence of a God protein which could be activated 
by excess GTP; analysis of  our Golgi preparations will deter- 
mine if such a hypothesis is correct. 
To explain the lack of a cytosol requirement for budding, 
we hypothesized that cytosolic factors may be tightly bound 
to the TGN and would require more stringent conditions for 
release. This hypothesis was correct since pretreatment of 
the permeabilized cells with high salt (400 mM KC1) re- 
sulted in no vesicle budding, unless the system was sup- 
plemented with either fresh cytosol or the dialyzed salt ex- 
tract.  In  either  case,  vesicle  formation was  restored  to 
control levels.  Prohormone processing was  unaffected by 
high  salt  treatment  of  the  permeabilized  cells  and  the 
efficiency of proSRIF cleavage was identical to that of con- 
trols (Table I). By analogy to intraGolgi transport (47, 71), 
we speculate that high salt treatment may remove coat pro- 
teins necessary for generating regulated pathway vesicles. 
These might include coat components common to all vesicu- 
lar transport systems, as well as those unique to the regulated 
pathway  such  as  specifiz clathrin-adaptor molecules  and 
GTP-binding proteins. Currently, we are analyzing the salt 
extract to identify components that specifically mediate bud- 
ding of regulated pathway secretory vesicles. 
Finally, this work demonstrates that prohormone cleavage, 
which requires an acidic milieu, is initiated in and precedes 
the release of nascent secretory vesicles from the TGN. We 
have shown that prohormone processing and vesicle forma- 
tion are separate biochemical reactions that occur during 
sorting to the regulated secretory pathway. Having demon- 
strated that both prohormone cleavage and budding of imma- 
ture secretory vesicles can occur in vitro, we can now exploit 
this system to identify components that facilitate the packag- 
ing of peptide hormones into specific regions of the TGN; 
these experiments are currently in progress. 
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Note Added in Proof Kuliawat and Aryan (J. Cell Biol.  1992. 118:521-529) 
have previously demonstrated that proinsulin processing is also inhibited 
when isolated rat islets are incubated at 20°C and is resumed upon warming 
to 37°C. 
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